Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly

被引:37
作者
Colao, Annamaria
Pivonello, Rosario
Cavallo, Luigi M.
Gaccione, Maria
Auriemma, Renata S.
Esposito, Felice
Cappabianca, Paolo
Lombardi, Gaetano
机构
[1] Univ Naples Federico II, Dept Mol & Clin Endocrinol & Oncol, Endocrinol Sect, I-80131 Naples, Italy
[2] Univ Naples Federico II, Dept Neurol Sci, Neurosurg Sect, I-80131 Naples, Italy
关键词
SPONTANEOUS GH SECRETION; DISEASE-ACTIVITY; OCTREOTIDE; MORTALITY; SURGERY; THERAPY;
D O I
10.1111/j.1365-2265.2006.02584.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background This analytical, retrospective study was designed to select cut-off thresholds of mean GH levels during a diurnal profile and nadir GH levels after oral glucose tolerance test (OGTT) according to age to diagnose surgical remission of acromegaly. Methods One hundred forty-one patients (76 women, aged 44 +/- 15 years and 65 men, aged 43 +/- 13 years) were included in this study. For the purpose of this study, remission was based on insulin-like growth factor-I (IGF-I) levels in the normal range for age. Diagnostic accuracy was analysed by receiving-operator characteristics (ROC) curves in the entire series, and in young (20-40 years), middle-aged (41-60 years) and older patients (> 60 years), separately. Results Sixty patients (42.6%) had normal IGF-I levels after surgery. In the entire series, in young and in middle-aged patients, the ROC analysis showed that optimum cut-off for mean GH levels was 2.3 mu g/l (diagnostic accuracy range, 94-97%) whereas that for nadir GH after OGTT were, respectively, 0.85, 0.9 and 0.8 mu g/l (diagnostic accuracy range, 90-95%). In the older patients, the optimum cut-off selected for mean GH levels was 1.4 mu g/l and that for nadir GH after OGTT was 0.5 mu g/l (diagnostic accuracy, 100% for both). The comparative analysis of the ROC curves did not show any significant difference between mean GH and nadir GH after OGTT (P = 0.21). Conclusions The criteria currently accepted for diagnosing post-surgical remission of acromegaly have high diagnostic accuracy only in the patients aged below 60 years. In older patients, lower cut-offs (i.e. = 1.4 mu g/l for fasting GH and = 0.5 mu g/l for nadir GH after OGTT) predict normal IGF-I levels. Mean GH levels during a diurnal profile have similar diagnostic accuracy of nadir GH levels after OGTT. This suggests that OGTT is not necessary to establish surgical cure.
引用
收藏
页码:250 / 256
页数:7
相关论文
共 35 条
  • [1] [Anonymous], 1996, World Health Organ Tech Rep Ser, V862, P1
  • [2] [Anonymous], 1999, Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation-Part 1: Diagnosis and Classification of Diabetes Mellitus
  • [3] Biochemical assessment and long-term monitoring in patients with acromegaly: Statement from a joint consensus conference of The Growth Hormone Research Society and The Pituitary Society
    Bengtsson, BA
    Carlsson, L
    Christianssen, JS
    Clemmons, D
    Frohman, L
    Ho, K
    Mullis, PE
    Robinson, I
    Strasburger, CJ
    Thorner, MO
    Vance, ML
    von Werder, K
    Freda, PU
    Holdaway, I
    Johansson, G
    Jorgensen, JOL
    Wass, J
    Barkan, A
    Brue, TC
    Chihara, K
    Colao, A
    de Herder, WW
    Malozowski, S
    Molitch, ME
    Orskov, H
    Schopohl, J
    Shalet, SM
    Stewart, PM
    Swearingen, B
    Trainer, PJ
    Anderberg, B
    Baister, L
    Friend, KE
    Harris, PE
    Hartman, ML
    Ispas-Jouron, S
    Kappelgaard, AM
    Knudsen, KW
    Konno, T
    Loumaye, E
    Musgrave, D
    Olivier, C
    Pedroncelli, A
    Shimatsu, A
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (07) : 3099 - 3102
  • [4] Determinants of survival in treated acromegaly in a single center: Predictive value of serial insulin-like growth factor I measurements
    Biermasz, NR
    Dekker, FW
    Pereira, AM
    van Thiel, SW
    Schutte, PJ
    van Dulken, H
    Romijn, JA
    Roelfsema, F
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) : 2789 - 2796
  • [5] Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women
    Burman, P
    Johansson, AG
    Siegbahn, A
    Vessby, B
    Karlsson, FA
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (02) : 550 - 555
  • [6] Castelli WP, 1996, ATHEROSCLEROSIS, V124, pS1, DOI 10.1016/0021-9150(96)05851-0
  • [7] CLEEMAN JI, 1988, ARCH INTERN MED, V148, P36, DOI 10.1001/archinte.148.1.36
  • [8] EVALUATION OF ACROMEGALY BY RADIOIMMUNOASSAY OF SOMATOMEDIN-C
    CLEMMONS, DR
    VANWYK, JJ
    RIDGWAY, EC
    KLIMAN, B
    KJELLBERG, RN
    UNDERWOOD, LE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1979, 301 (21) : 1138 - 1142
  • [9] First-line octreotide-LAR therapy induces tumour shrinkage and controls hormone excess in patients with acromegaly: results from an open, prospective, multicentre trial
    Colao, A
    Pivonello, R
    Rosato, F
    Tita, P
    Menis, E
    Barreca, A
    Ferrara, R
    Mainini, F
    Arosio, M
    Lombardi, G
    [J]. CLINICAL ENDOCRINOLOGY, 2006, 64 (03) : 342 - 351
  • [10] Gender- and age-related differences in the endocrine parameters of acromegaly
    Colao, A
    Amato, G
    Pedroncelli, AM
    Baldelli, R
    Grottoli, S
    Gasco, V
    Petretta, M
    Carella, C
    Pagani, G
    Tamburano, G
    Lombardi, G
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2002, 25 (06) : 532 - 538